Alloplex Biotherapeutics
Boston
About Alloplex Biotherapeutics
Alloplex Biotherapeutics operates as a privately-owned Boston-based cellular therapeutics company. It has developed a non-engineered, tumor-agnostic cellular therapy platform with broad anti-tumor activity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $21.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2023)
- Website: alloplexbio.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/alloplex-biotherapeutics-44007 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.